Doctors’ leaders have welcomed moves to ease the workload of GPs, enabling them to focus on the Covid booster jab rollout, but warned the service remains under “significant” pressure.
Following the decision to ramp up the vaccination programme, NHS England has told GPs other targets may be suspended and routine health checks for the over-75s and for new patients can be deferred.
The move comes after the Government announced it was extending booster jabs to all adults and cutting the time between the second and third doses from six to three months amid fears about the spread of the new Omicron variant.
Ministers have promised a “national mission” to ensure everyone who is eligible can get a booking by the end of January, but have acknowledged it represents a “huge ask” for the NHS.
“We have been struggling with significant prevailing workforce pressures – backlog pressures, winter pressures, pandemic pressures,” she told the BBC Radio 4 Today programme.
“Whilst these changes make a difference and start to create some time, I think every single practice will have to look at just how much time it does release.
“What it will do is free up staff time who are busy filling some of these tick-box exercises, so some of our staff can be redeployed to the vaccination effort.”
The latest cases take the total for England to 104 and for the UK as a whole to 134 – including 29 in Scotland and the first confirmed case in Wales.
The HSA said that in England Omicron cases have now been identified in East Midlands, East of England, London, North East, North West, South East, South West and West Midlands.
Individuals who have tested positive for the variant and their contacts are being asked to self-isolate while the HSA said it was carrying out targeted testing at locations where the positive cases were thought likely to be infectious.
HSA chief executive Dr Jenny Harries said: “We are continuing to monitor the data closely. Teams nationally and locally are working at pace to identify and trace all close contacts of every Omicron case.
The figures came as a risk assessment by the HSA rated the new Omicron variant as “red” for severity of infection and “amber” for transmissibility between humans.
It said the variant, first identified in South Africa, was likely to reduce the protection from both naturally or vaccine-acquired immunity.
However it acknowledged there was so far “insufficient data” to reach firm conclusions and the assessment was presented with “low confidence”.
Dr Harries said: “We are working as fast as possible to gather more evidence about any impact the new variant may have on severity of disease or vaccine effectiveness.
“Until we have this evidence, we must exercise the highest level of caution in drawing conclusions about any significant risks to people’s health.”